Northwestern Mutual Wealth Management’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$56.4K Buy
1,445
+579
+67% +$18.7K ﹤0.01% 2493
2026
Q1
$28.2K Buy
866
+250
+41% +$8.04K ﹤0.01% 2673
2025
Q4
$21.7K Sell
616
-746
-55% -$26.4K ﹤0.01% 2717
2025
Q3
$35.8K Sell
1,362
-747
-35% -$22.3K ﹤0.01% 2463
2025
Q2
$55.9K Buy
2,109
+481
+30% +$12.7K ﹤0.01% 2211
2025
Q1
$39.3K Buy
1,628
+48
+3% +$1.52K ﹤0.01% 2266
2024
Q4
$63.6K Buy
1,580
+1,552
+5,543% +$88.5K ﹤0.01% 2097
2024
Q3
$1.77K Buy
+28
New +$1.64K ﹤0.01% 3142
2024
Q1
Sell
-1,388
Closed -$25.8K 3829
2023
Q4
$25.8K Buy
+1,388
New +$18.2K ﹤0.01% 2313
2022
Q3
Sell
-550
Closed -$2K 3423
2022
Q2
$2K Hold
550
﹤0.01% 2955
2022
Q1
$2K Hold
550
﹤0.01% 2938
2021
Q4
$3K Buy
+550
New +$3.08K ﹤0.01% 2905
2020
Q4
Sell
-300
Closed -$2K 2891
2020
Q3
$2K Buy
+300
New +$2.07K ﹤0.01% 2380
2020
Q2
Sell
-58
Closed 2707
2020
Q1
$0 Buy
+58
New +$357 ﹤0.01% 2766
2019
Q2
Sell
-76
Closed -$1K 2721
2019
Q1
$1K Buy
+76
New +$636 ﹤0.01% 2463

Other funds holding VKTX

Northwestern Mutual Wealth Management's VKTX Position: Q2 2026 in Review

Northwestern Mutual Wealth Management increased its Viking Therapeutics (VKTX) stake by 67% in Q2 2026, buying an estimated $18.7K and bringing the position to 1,445 shares worth $56.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2493.

Northwestern Mutual Wealth Management first reported a position in VKTX in Q1 2019 and has held it in 15 quarters since. The position peaked at $63.6K in Q4 2024. 432 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

  • Northwestern Mutual Wealth Management held 1,445 shares of Viking Therapeutics worth $56.4K as of Q2 2026.
  • Northwestern Mutual Wealth Management bought 579 Viking Therapeutics shares in Q2 2026, an estimated $18.7K.
  • Viking Therapeutics made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q2 2026, its #2493 holding.
  • Northwestern Mutual Wealth Management first reported a position in Viking Therapeutics in Q1 2019 and has held it in 15 quarters since.
  • Northwestern Mutual Wealth Management's Viking Therapeutics position peaked at $63.6K in Q4 2024.
  • 432 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.